Form D · Biotechnology
TheRas, Inc.
Palo Alto, CA · CIK 0002022953
Offering snapshot reported May 15, 2024 · SEC filing
- Reported sold
- $200M Offering amount: $200M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 30, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 15, 2024 | Initial | $200,000,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-513303
Source: Form D, filed May 15, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Pedro Beltran | Executive |
| Michelle Doig | Director |
| Idan Elmelech | Executive |
| Raymond Kelleher | Director |
| Neil Kumar | Director |
| Frank Mc Cormick | Director |
| Eli Wallace | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3160 Porter Drive Suite 250
Palo Alto, CA, 94304
Palo Alto, CA, 94304